Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Hilary Duff releases 'Mature,' her 1st song in 10 years - 2An Excursion Through Renowned Western Network programs
- 3Linda Hamilton, 69, says she doesn't want to 'chase longevity'
- 4Airport wait times won't return to normal until Congress reaches a deal to pay TSA. Here's why they still can't come to an agreement.
- 5US measles cases surpass 2,000, highest in 30 years: CDC
- As juries turn against social media for harming kids, Big Tech's invincibility starts to show cracks
- Sally Rooney books may be withdrawn from UK sale over Palestine Action ban, court told
- Figure out How to Establish a long term connection with Your Handshake
- Avoid This Common Mistake When Planning Sightseeing Activities For Your Trip To Italy
- The Electric Bicycle Americans Can Confide in 2024
- 'The Drama' plot twist, explained: What did Zendaya's character do, and what happens to her wedding?
- Obamacare enrollment declines as US subsidies expire
- Benin coup thwarted by loyalist troops, president tells nation
- Storm Goretti sweeps United Kingdom, France with winds over 120 mph
